Canandaigua National Corp’s Boston Scientific BSX Stock Holding History

Canandaigua National Corp’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$974K	Buy	21,051 +2,531	+14%	+$110K	0.17%	132
2022 Q3	$717K	Buy	18,520 +2,237	+14%	+$89.7K	0.13%	149
2022 Q2	$607K	Sell	16,283 -1,225	-7%	-$49.9K	0.11%	160
2022 Q1	$775K	Sell	17,508 -342	-2%	-$14.8K	0.12%	158
2021 Q4	$758K	Sell	17,850 -240	-1%	-$10.1K	0.11%	161
2021 Q3	$785K	Buy	18,090 +27	+0.1%	+$1.2K	0.13%	152
2021 Q2	$772K	Sell	18,063 -220	-1%	-$9.26K	0.13%	152
2021 Q1	$707K	Buy	18,283 +166	+0.9%	+$6.28K	0.12%	158
2020 Q4	$651K	Buy	18,117 +5,835	+48%	+$210K	0.11%	151
2020 Q3	$469K	Buy	12,282 +29	+0.2%	+$1.12K	0.08%	169
2020 Q2	$430K	Buy	+12,253	New	+$441K	0.08%	172

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Canandaigua National Corp's BSX Position: Q4 2022 in Review

Canandaigua National Corp increased its Boston Scientific (BSX) stake by 14% in Q4 2022, buying an estimated $110K and bringing the position to 21,051 shares worth $974K. The position accounts for 0.17% of the portfolio, ranked #132.

Canandaigua National Corp first reported a position in BSX in Q2 2020 and has held it in 11 quarters since. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

Canandaigua National Corp held 21,051 shares of Boston Scientific worth $974K as of Q4 2022.
Canandaigua National Corp bought 2,531 Boston Scientific shares in Q4 2022, an estimated $110K.
Boston Scientific made up 0.17% of Canandaigua National Corp's portfolio in Q4 2022, its #132 holding.
Canandaigua National Corp first reported a position in Boston Scientific in Q2 2020 and has held it in 11 quarters since.
928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Canandaigua National Corp's 13F filing for Q4 2022, filed 25 Jan 2023.